Full Press Release Details
NEW YORK and WALTHAM, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced that the Company’s senior management team will participate in the following upcoming investor healthcare conferences during the month of November:
Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology Conference on November 6 in New York City
Jefferies 2023 London Healthcare Conference on November 14-15 in London
Evercore ISI 6th Annual HealthCONx Conference on November 28-29 in Miami
About Dianthus Therapeutics
Verge Scientific Communications